Kojima K, Ohno K, Kanemoto H, Goto-Koshino Y, Fukushima K, Tsujimoto H
Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, 113-8657, Japan.
J Small Anim Pract. 2017 May;58(5):257-262. doi: 10.1111/jsap.12623. Epub 2017 Jan 30.
To reveal the relationship between canine corticosteroid-induced alkaline phosphatase isoenzyme activity and hepatobiliary diseases.
Retrospective analysis of the relationship between serum corticosteroid-induced alkaline phosphatase activity and diagnosis, serum cortisol concentration and alanine transferase activity in dogs with hepatobiliary diseases. Dogs with a history of glucocorticoid administration were excluded.
Seventy-two dogs with hepatobiliary diseases were analysed. The serum corticosteroid-induced alkaline phosphatase concentration was increased in dogs with hepatobiliary diseases. There was no correlation between serum cortisol concentration and serum corticosteroid-induced alkaline phosphatase percentage or activity.
Dogs with hepatobiliary disease can exhibit high serum alkaline phosphatase activity even if the dogs have not been administrated glucocorticoids and the serum cortisol concentration is normal.
揭示犬皮质类固醇诱导的碱性磷酸酶同工酶活性与肝胆疾病之间的关系。
回顾性分析患有肝胆疾病的犬血清皮质类固醇诱导的碱性磷酸酶活性与诊断、血清皮质醇浓度及丙氨酸转氨酶活性之间的关系。排除有糖皮质激素给药史的犬。
分析了72只患有肝胆疾病的犬。患有肝胆疾病的犬血清皮质类固醇诱导的碱性磷酸酶浓度升高。血清皮质醇浓度与血清皮质类固醇诱导的碱性磷酸酶百分比或活性之间无相关性。
即使未给予糖皮质激素且血清皮质醇浓度正常,患有肝胆疾病的犬也可表现出高血清碱性磷酸酶活性。